
<DOC>
<DOCNO>
WSJ900404-0031
</DOCNO>
<DOCID>
900404-0031.
</DOCID>
<HL>
   International Brief -- Fermenta AB:
   Company Plans to Raise
   Liquidity Via Divestiture
</HL>
<DATE>
04/04/90
</DATE>
<SO>
WALL STREET JOURNAL (J), PAGE A20
</SO>
<CO>
   S.FER
</CO>
<IN>
TENDER OFFERS, MERGERS, ACQUISITIONS (TNM)
MEDICAL AND BIOTECHNOLOGY (MTC)
</IN>
<LP>
   Swedish biotechnology group Fermenta AB said it decided to
divest itself of its U.S. subsidiaries SDS and Fermenta
Animal Health to raise its liquidity.
   Fermenta declined to disclose the price for the two
companies, but according to Swedish news reports they total
about 2.5 billion Swedish kronor ($407 million).
</LP>
<TEXT>
   SDS, which had sales of about 1.2 billion kronor last
year, produces, markets and develops pesticides. Animal
Health is one of the leading U.S. veterinary medicine
companies and had sales amounting to 463 million kronor in
1989.
   The two companies will be divested by tender offer,
organized by the investment bank Dillon Read, Fermenta said.
</TEXT>
</DOC>